These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8809347)

  • 21. Hypoglycemia, hypotonia, and cardiomyopathy: the evolving clinical picture of long-chain acyl-CoA dehydrogenase deficiency.
    Treem WR; Stanley CA; Hale DE; Leopold HB; Hyams JS
    Pediatrics; 1991 Mar; 87(3):328-33. PubMed ID: 2000272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
    Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
    Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Very long chain acyl-CoA dehydrogenase deficiency in a pair of mildly affected monozygotic twin sister in their late fifties.
    Zia A; Kolodny EH; Pastores GM
    J Inherit Metab Dis; 2007 Oct; 30(5):817. PubMed ID: 17514507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunochemical characterization of variant long-chain acyl-CoA dehydrogenase in cultured fibroblasts from nine patients with long-chain acyl-CoA dehydrogenase deficiency.
    Indo Y; Coates PM; Hale DE; Tanaka K
    Pediatr Res; 1991 Sep; 30(3):211-5. PubMed ID: 1945557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients.
    Baruteau J; Sachs P; Broué P; Brivet M; Abdoul H; Vianey-Saban C; Ogier de Baulny H
    J Inherit Metab Dis; 2013 Sep; 36(5):795-803. PubMed ID: 23053472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of dietary fatty acid chain-length on metabolic tolerance in mouse models of inherited defects in mitochondrial fatty acid beta-oxidation.
    Schuler AM; Gower BA; Matern D; Rinaldo P; Wood PA
    Mol Genet Metab; 2004 Dec; 83(4):322-9. PubMed ID: 15589119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels.
    Stanley CA; Hale DE; Coates PM; Hall CL; Corkey BE; Yang W; Kelley RI; Gonzales EL; Williamson JR; Baker L
    Pediatr Res; 1983 Nov; 17(11):877-84. PubMed ID: 6646897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful Treatment of Cardiomyopathy due to Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: First Case Report from Oman with Literature Review.
    Sharef SW; Al-Senaidi K; Joshi SN
    Oman Med J; 2013 Sep; 28(5):354-6. PubMed ID: 24044064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death.
    Mathur A; Sims HF; Gopalakrishnan D; Gibson B; Rinaldo P; Vockley J; Hug G; Strauss AW
    Circulation; 1999 Mar; 99(10):1337-43. PubMed ID: 10077518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute, severe cardiomyopathy as main symptom of late-onset very long-chain acyl-coenzyme A dehydrogenase deficiency.
    Parini R; Menni F; Garavaglia B; Fesslova V; Melotti D; Massone ML; Lamantea E; Rimoldi M; Vizziello P; Gatti R
    Eur J Pediatr; 1998 Dec; 157(12):992-5. PubMed ID: 9877038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop.
    Spiekerkoetter U; Lindner M; Santer R; Grotzke M; Baumgartner MR; Boehles H; Das A; Haase C; Hennermann JB; Karall D; de Klerk H; Knerr I; Koch HG; Plecko B; Röschinger W; Schwab KO; Scheible D; Wijburg FA; Zschocke J; Mayatepek E; Wendel U
    J Inherit Metab Dis; 2009 Aug; 32(4):488-97. PubMed ID: 19399638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy.
    Gobin-Limballe S; Djouadi F; Aubey F; Olpin S; Andresen BS; Yamaguchi S; Mandel H; Fukao T; Ruiter JP; Wanders RJ; McAndrew R; Kim JJ; Bastin J
    Am J Hum Genet; 2007 Dec; 81(6):1133-43. PubMed ID: 17999356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expert consensus on diagnosis and treatment of very long-chain acyl-CoA dehydrogenase deficiency.
    Division of Biochemistry and Metabolism, Medical Genetics Branch, Chinese Medical Association ; Division of Genetics and Metabolism, Child Diseases and Health Care Branch, Chinese Association for Maternal and Child Health
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 51(1):122-128. PubMed ID: 36161784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro fibroblast studies in a patient with C6-C10-dicarboxylic aciduria: evidence for a defect in general acyl-CoA dehydrogenase.
    Kølvraa S; Gregersen N; Christensen E; Hobolth N
    Clin Chim Acta; 1982 Nov; 126(1):53-67. PubMed ID: 7172449
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-chain fatty acid oxidation during early human development.
    Oey NA; den Boer ME; Wijburg FA; Vekemans M; Augé J; Steiner C; Wanders RJ; Waterham HR; Ruiter JP; Attié-Bitach T
    Pediatr Res; 2005 Jun; 57(6):755-9. PubMed ID: 15845636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
    Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
    Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dicarboxylic aciduria: deficient [1-14C]octanoate oxidation and medium-chain acyl-CoA dehydrogenase in fibroblasts.
    Rhead WJ; Amendt BA; Fritchman KS; Felts SJ
    Science; 1983 Jul; 221(4605):73-5. PubMed ID: 6857268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood.
    Strauss AW; Powell CK; Hale DE; Anderson MM; Ahuja A; Brackett JC; Sims HF
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10496-500. PubMed ID: 7479827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: protective effect of medium-chain triglyceride treatment.
    Duran M; Wanders RJ; de Jager JP; Dorland L; Bruinvis L; Ketting D; Ijlst L; van Sprang FJ
    Eur J Pediatr; 1991 Jan; 150(3):190-5. PubMed ID: 2044590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proposal for an individualized dietary strategy in patients with very long-chain acyl-CoA dehydrogenase deficiency.
    Bleeker JC; Kok IL; Ferdinandusse S; de Vries M; Derks TGJ; Mulder MF; Williams M; Gozalbo ER; Bosch AM; van den Hurk DT; de Sain-van der Velden MGM; Waterham HR; Wijburg FA; Visser G
    J Inherit Metab Dis; 2019 Jan; 42(1):159-168. PubMed ID: 30740737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.